Achieving the composite end‐point of glycated hemoglobin

Autor: Xinhua Xiao, Changjiang Wang, Xiaoyang Lai, Bin Zhang, Liqun Gu, Jianing Hou, Zhiguang Zhou

Publikováno v: Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 647-652 (2020)

Abstract Aims/Introduction To assess the effect of dulaglutide (DU) 1.5/0.75 mg in comparison with glimepiride (GLIM) or insulin glargine (GLAR) on the composite end‐point in Chinese type 2 diabetes patients. Materials and Methods Post‐hoc analys

Externí odkaz: https://doaj.org/article/2e4fcafb71124470947a47178dec5654

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment with tear substitutes

Autor: Yasmina Iffet Eroglu

Publikováno v: Journal of Market Access & Health Policy, Vol 5, Iss 1 (2017)

Background: In 2015, Ikervis® became the only EMA-approved cyclosporine A (CsA) eye-drop for the treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes. Since the 1980s, C

Externí odkaz: https://doaj.org/article/e783e3eded8145bbabb10742694c9805

Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy

Autor: Toni Sarapohja, Fabrizio Morandi, Paola Beltrán, Gerhard Pölzl, Roman Pfister, Matti Kivikko, Piero Pollesello, Johann Altenberger, Dirk von Lewinski, Mirko Seidel, Gian Piero Perna, Josep Comín-Colet, Attila Borbély, Ramón Bover, Martín J. García-González, Friedrich Fruhwald, George Giannakoulas, Loant Baholli, Martin Martínez-Sellés, Alexander Reinecke, Bojan Vrtovec, Juan F. Delgado, Gabriella Malfatto, Alejandro Recio-Mayoral, Josep Masip, Stefan Störk, Fabrizio Oliva, Gregory Giamouzis, Finn Gustafsson, Patrik Yerly, Diego Rangel-Sousa, Kari Kaikkonen, Ida Löfman, Zoltán Papp, Henning Mølgaard, Gunter Schmidt, Nicolás Manito, Antonella Fontana, Francesco Fedele, Gerhard Wikström, Vito Piazza, Emil Pantev, Béla Merkely, Jacek Kubica, Andreas Rieth

Publikováno v: Poelzl, G, Altenberger, J, Baholli, L, Beltran, P, Borbely, A, Comin-Colet, J, Delgado, J F, Fedele, F, Fontana, A, Fruhwald, F, Giamouzis, G, Giannakoulas, G, Garcia-Gonzalez, M J, Gustafsson, F, Kaikkonen, K, Kivikko, M, Kubica, J, von Lewinski, D, Lofman, I, Malfatto, G, Manito, N, Martinez-Selles, M, Masip, J, Merkely, B, Morandi, F, Molgaard, H, Oliva, F, Pantev, E, Papp, Z, Perna, G P, Pfister, R, Piazza, V, Bover, R, Rangel-Sousa, D, Recio-Mayoral, A, Reinecke, A, Rieth, A, Sarapohja, T, Schmidt, G, Seidel, M, Stoerk, S, Vrtovec, B, Wikstroem, G, Yerly, P & Pollesello, P 2017, ' Repetitive use of levosimendan in advanced heart failure : need for stronger evidence in a field in dire need of a useful therapy ', International Journal of Cardiology, vol. 243, pp. 389-395 . https://doi.org/10.1016/j.ijcard.2017.05.081

Patients in the latest stages of heart failure are severely compromised, with poor quality of life and frequent hospitalizations. Heart transplantation and left ventricular assist device implantation are viable options only for a minority, and interm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb92f299208040c61f7984071f0b8ce9
https://doi.org/10.1016/j.ijcard.2017.05.081

ERAS

Publikováno v: Journal of Surgical Oncology. 116(5):617-622

The enhanced recovery after surgery (ERAS) program has reduced postoperative morbidity and duration of hospital stay but not mortality in patients undergoing hepatopancreatobiliary (HPB) surgery. Many HPB patients suffer from cancer cachexia, a syndr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od________83::28a93c3348fc8c81026bc459a19ba232
https://cris.maastrichtuniversity.nl/en/publications/4ed2c1e2-457a-41b8-9ca4-4ae6ef7fadf5